研究设计与统计指南

订阅

MedSci主页 / 所有栏目 / 研究设计与统计指南

肾功能损害患者的药代动力学研究技术指导原则

2019-10-31 国家药品监督管理局药品审评中心（CDE）

肾功能损害

肾功能损害患者的药代动力学研究技术指导原则

中文标题：

肾功能损害患者的药代动力学研究技术指导原则

发布机构：

国家药品监督管理局药品审评中心（CDE）

发布日期：

2019-10-31

简要介绍：

肾功能损害患者的药代动力学研究技术指导原则

相关资料下载：
[AttachmentFileName(sort=100, fileName=肾功能损害患者的药代动力学研究技术指导原则)] GetToolGuiderByIdResponse(projectId=1, id=c13ab1c00181e54a, title=肾功能损害患者的药代动力学研究技术指导原则, enTitle=, guiderFrom=, authorId=null, author=, summary=肾功能损害患者的药代动力学研究技术指导原则, cover=, journalId=null, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心（CDE）, associationIntro=国家药品监督管理局药品审评中心（CDE）, copyright=0, guiderPublishedTime=Thu Oct 31 05:38:31 CST 2019, originalUrl=, linkOutUrl=, content=肾功能损害患者的药代动力学研究技术指导原则, tagList=[TagDto(tagId=8900, tagName=肾功能损害)], categoryList=[CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1646, appHits=63, showAppHits=0, pcHits=687, showPcHits=1436, likes=25, shares=2, comments=2, approvalStatus=1, publishedTime=Thu Oct 31 05:38:31 CST 2019, publishedTimeString=2019-10-31, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Thu Oct 31 05:38:31 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 01:18:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=肾功能损害患者的药代动力学研究技术指导原则)])
肾功能损害患者的药代动力学研究技术指导原则
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1016296, encodeId=60951016296e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5478339, createdName=ms6000000982118255, createdTime=Fri Sep 10 12:26:30 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948015, encodeId=d190948015ef, content=能有摘要就好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c355468558, createdName=徐海霞, createdTime=Sun Mar 14 09:29:11 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
    2021-09-10 ms6000000982118255

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1016296, encodeId=60951016296e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5478339, createdName=ms6000000982118255, createdTime=Fri Sep 10 12:26:30 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948015, encodeId=d190948015ef, content=能有摘要就好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c355468558, createdName=徐海霞, createdTime=Sun Mar 14 09:29:11 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
    2021-03-14 徐海霞

    能有摘要就好

    0